United States College of Pathology Glioma External Quality Control Program (unsterilized)
Taiwan·Risk Class 1·COLLEGE OF AMERICAN PATHOLOGISTS;; Cleveland Clinic Foundation·Registered Nov 12, 2024 – Nov 12, 2029Active- Analysis ID
- c71a1b3a2290b9138955fb518cfbfdc9
- Customs Code
- DHA09402367401
- Manufacturer Country
- United States
- Authorized Representative
- HOLLING BIO-PHARMA. CORP.
- Intended Use
- It is limited to the scope of the first class of the medical equipment classification and classification management method "Quality Control Materials (Analytical and Non-Analytical) (A.1660)".
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- Contract manufacturing;; input
- Registration Date
- Nov 12, 2024
- Expiry Date
- Nov 12, 2029
Access comprehensive regulatory information for United States College of Pathology Glioma External Quality Control Program (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c71a1b3a2290b9138955fb518cfbfdc9 and manufactured by COLLEGE OF AMERICAN PATHOLOGISTS;; Cleveland Clinic Foundation. The authorized representative in Taiwan is HOLLING BIO-PHARMA. CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.